Introduction
Patients with epilepsy often complain of poor sleep and excessive daytime sleepiness (EDS) that affect quality of life in addition to epilepsy per se. [1] [2] [3] Summary The aim of the study was to assess sleep-wake habits and disorders and excessive daytime sleepiness (EDS) in an unselected outpatient epilepsy population. Sleep-wake habits and presence of sleep disorders were assessed by means of a clinical interview and a standard questionnaire in 100 consecutive patients with epilepsy and 90 controls. The questionnaire includes three validated instruments: the Epworth Sleepiness Scale (ESS) for EDS, SA-SDQ for sleep apnea (SA), and the Ullanlinna Narcolepsy Scale (UNS) for narcolepsy. Sleep complaints were reported by 30% of epilepsy patients compared to 10% of controls ( p = 0.001). The average total sleep time was similar in both groups. Insufficient sleep times were suspected in 24% of patients and 33% of controls. Sleep maintenance insomnia was more frequent in epilepsy patients (52% vs. 38%, p = 0.06), whereas nightmares (6% vs. 16%, p = 0.04) and bruxism (10% vs. 19%, p = 0.07) were more frequent in controls. Sleep onset insomnia (34% vs. 28%), EDS (ESS 10, 19% vs. 14%), SA (9% vs. 3%), restless legs symptoms (RL-symptoms, 18% vs. 12%) and most parasomnias were similarly frequent in both groups. In a stepwise logistic regression model loud snoring and RL-symptoms were found to be the only independent predictors of EDS in epilepsy patients. In conclusion, sleep-wake habits and the frequency of most sleep disorders are similar in non-selected epilepsy patients as compared to controls. In epilepsy patients, EDS was predicted by a history of loud snoring and RL-symptoms but not by SA or epilepsyrelated variables (including type of epilepsy, frequency of seizures, and number of antiepileptic drugs). # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
In selected clinical series sleep architecture changes (polysomnography) and EDS (Multiple Sleep Latency Test, MSLT) have been frequently found. [4] [5] [6] [7] Studies on the frequency of sleep disorders in patients with epilepsy remain, however, contradictory. The frequency of obstructive sleep apnoea (OSA) has varied between 10% and 65% [8] [9] [10] [11] [12] [13] [14] [15] and that of restless legs syndrome/PMLS between 10% and 33%. 5, 16, 17 The frequency of parasomnias in adult epilepsy patients is unknown. 18 In patients with epilepsy EDS may be as high as 11-28%. 10, 19 While EDS has often been referred to side effects of antiepileptic drugs (AEDs) 1 or to poor seizure control, 19 insufficient sleep and concomitant sleep disorders have also been suggested. 8, 9, 17 Most data on the frequency of sleep disorders and EDS in patients with epilepsy are restricted to small study populations and to publications published in abstract form only. [20] [21] [22] [23] [24] The aim of this study was to assess sleep-wake habits and the frequency of sleep disorders and EDS in an unselected epilepsy population.
Patients and methods
Over a period of 16 weeks, all patients referred to the epilepsy outpatient clinics of the Neurology Departments of the University Hospitals in Zürich and Berne were prospectively assessed for sleep wake habits and disorders by means of a structured interview and a standardised questionnaire. Only patients older than 18 years with a confirmed diagnosis of epilepsy as defined according to the criteria of International League Against Epilepsy (ILAE) were included into the study. Patients with major cognitive deficits (n = 3) and patients with insufficient language knowledge (n = 1) were excluded. Healthy subjects were recruited from hospital staff and their relatives by advertisement or mouth to mouth propagada. All subjects participated voluntarily the study without being paid. A history of neurologic, psychiatric or severe medical diseases was excluded by interview. Subjects with spontaneous reports of sleep complaints and use of hypnotics over the last 4 weeks drugs were excluded from the study. The sleep questionnaire includes 108 questions addressing sleep-wake habits and complaints. The answers provide informations on symptoms/signs suggestive of sleep apnoea (SA), EDS, narcolepsy, different parasomnias, insomnia and disturbances of the sleep-wake rhythm. Possible answers included ''yes'' and ''no'' or provided a rating on a 5 point scale depending on the frequency of occurrence (''almost always'', ''often'', ''occasionally'', ''seldom'' or ''never''). For binary variables, ''never'' and ''seldom'' were coded as ''no'' and ''occasionally'', ''often'' and ''almost always'' were coded as ''yes''. Three validated scores are included in the questionnaire. The Epworth Sleepiness Scale (ESS), a scale for assessment of subjective excessive daytime sleepiness based on eight questions on the urge to sleep in various life situations. 25 Each question is rated on a 4 point scale ranging from 0 to 3 points, thus resulting in a maximum sum score of 24 points. A cut-off score of 10 is considered abnormal. The Sleep Apnea Scale of the Sleep Disorders Questionnaire (SA-SDQ) is a screening instrument for obstructive sleep apnea. 26 The SA-SDQ consists of 12-items for sleep-related breathing disorders and includes well-known risk factors age and BMI. Cut-off scores in non-epileptic patients are 32 for women and 36 for men (range is 12-60) provided a sensitivity of 85% and a specificity of 72% for males and 88% and 81% for females, respectively. 15 The 11-item Ullanlinna Narcolepsy Scale (UNS) is a widely used screening instrument for narcolepsy. It is validated in a variety of studies and has a high interater reability. 27 A cutoff of 14 has been shown to have a high sensitivity (100-96%) but a variable specificity (99-56%) for patients with narcolepsy-cataplexy. 27, 28 Due to limited space the questionnaire included only a single question related to Restless Legs Syndrome (RLS), i.e. asking for a sensory discomfort in the evening/night associated with an urge to move or rub the legs. Because only three out of four diagnostic criteria of RLS are covered by this question we used the term restless legs symptoms (RL-symptoms) instead of restless legs syndrome (RLS) throughout the text. Clinical data including neurological examination, semiology and frequency of seizures during the last 3 months and antiepileptic drugs (AEDs) were documented. Immediately after consultation patients received the sleep questionnaire. Three weeks after initial visit all patients who had not sent back the questionnaire were asked by phone to return the form. Responder rate was 80% with a total of 100 out of 125 questionnaires completed.
Statistics
Univariate and bivariate analyses: depending on categorical or continuous variable and the distribution of the data Chi-square Test/Fisher's Exact Test, unpaired Student's t-test or Kruskal Wallis Test were performed. Pearsońs Product or Spearman's rank correlation were performed when appropriate. The level of significance was 0.05 in all tests. All variables associated with the dependent variable (i.e. EDS/no EDS, SA/no SA) were included in a stepwise logistic regression model to test their predictive value on the dependent variable. All tests were calculated using SPSS (statistical package for social sciences, Version 11.0.1).
Results (see also Tables 1 and 2)
Mean age (47 years vs. 44 years) was similar in both groups, but BMI and gender distribution significantly differed between epilepsy patients and controls. There were more males in the epilepsy group (63% vs. 46%, p = 0.02) and patients had a significantly higher BMI (25 vs. 23, p > 0.001). Epilepsy was focal in 60% and generalized in 40% of patients (idiopathic generalized epilepsies in 10%, secondary generalized in 30%). The most common types of seizures were simple partial (15%), complex partial (46%), and generalized (in 54%). Onethird of patients had more than one seizure type. Sixty-two of patients were seizure free within the last 3 month, 14% had 1-2 seizures/month, 7% 3-6 seizures/month (''monthly''), 14% 7-12 seizures/month (''weekly''), and 3% had daily seizures. In 39% of patients seizures predominated or occurred only during sleep.
The patients received on average 1.4 AEDs (range: 0-4) and the mean duration of treatment was 13 years (range: 0-60). Most of the patients (63%) were treated in monotherapy (i.e. carbamazepine: 40%, valproate: 30%, phenytoin: 22%, other: 8%), 20% received two AEDs and 12% three or more AEDs. A minority of 5% took no AED at all. In 31% of the patients epilepsy was considered refractory to AEDs as defined by a failure of three or more AEDs.
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Sleep-wake habits
The average total sleep time (7.5 h/night) was similar in epilepsy patients and controls, as well as in patients with idiopathic generalized (n = 10; 7.3 h) and focal epilepsy (n = 59; 7.5 h; p = 0.7). Three patients with epilepsy and one patient in the control group reported an average total sleep time of >10 h. An average total sleep time of <6 h was reported by seven patients with epilepsy (five with focal epilepsy) and by one control. A significant percentage of patients (24%) and controls (33%) reported that their time in bed on week-ends was 2 h than during week-days, suggesting the presence of a chronic sleep insufficiency.
Sleep complaints and insomnia
Subjective sleep complaints were reported by 30% of the epilepsy patients and 10% of controls 
Excessive daytime sleepiness (EDS)
The frequency of EDS was similar in both groups, as assessed by subjective estimation (37% vs. 32%) or by an abnormal Epworth sleepiness score (ESS 10, 19% vs. 14%). Problems at work (9% vs. 2%, p = 0.06) and traffic accidents related to fatigue or EDS were more frequent in patients with epilepsy than in controls (14% vs. 1%, p = 0.008).
The ESS correlated with age (r = 0.18, p = 0.01), history of loud snoring (r = 0.20, p = 0.008) and nocturnal pauses while breathing (r = 0.24, p = 0.002). A stepwise logistic regression of 157 subjects including age, sex, epilepsy-controls, BMI, hours of sleep, RL-symptoms, loud snoring, pauses in breathing, sleep onset and sleep maintenance the model could only explain 7% of the variance. Only loud snoring ( p = 0.02; odds ratio 1.9; 95%-CI: 1.1-3.2) was an independent predictor of sleepiness for epilepsy patients. When including SA-SDQ (instead of loud snoring, pauses in breathing and BMI which are included in the SA-SDQ score) RL-symptoms had a significant predictive value ( p = 0.01, odds ratio 2.1, 95%-CI: 1.2-3.8) and the model could explain 27% of the variance. To investigate the impact of epilepsy and antiepileptic drugs on EDS (ESS < 10 vs. ESS 10) a stepwise logistic regression model included the following variables: (1) type (focal vs. generalized) and frequency of seizures (less than monthly vs. once a month or more), (2) presence/absence of nocturnal seizures, (3) etiology of epilepsy (symptomatic vs. idiopathic), (4) duration of epilepsy, (5) number and type of AEDs, (6) duration of AED-treatment, (7) AED-refractory/-responsive epilepsy, (8) sex, (9) age. None of these factors was found to be an independent predictor of EDS.
A small proportion (7/190; 4%) of our sample rated themselves as severely sleepy with an ESS score (>14) comparable to that of narcoleptic patients. 27 Among them 86% (6/7) were epilepsy patients but none of them had cataplexy. Seizure type, seizure frequency or specific AED did not contribute to EDS. Four of these six patients were seizure-free and only one patient has been estimated as medically refractory. However, comorbidity with various sleep disorders may be relevant in these patients: SAS in two patients, RL-symptoms in two patients, nocturnal leg cramps in one patient (for details see Table 3 ).
Sleep apnoea (SA)
Based on SA-SDQ-scale nine patients (five men, four women) and two controls (one men, one woman) had an abnormal score (>32 for female; >36 for male 26 ) suggestive of SA. Using a less conservative cut-off score recently suggested for epilepsy patients 15 30% of epilepsy patients (16 men, 14 women) and 23% of controls (10 male, 6 female) met the chosen criteria for SA. All but one of these epilepsy patients were older than 50 years. BMI was, conversely, similar in epilepsy patients with and without SA.
Restless legs symptoms (RL-symptoms)
The frequency of RL-symptoms, as assessed by a single question (see Section 'Methods'), did not differ between patients (18%) and controls (12%). There was a significant correlation between RLsymptoms and age (r = 0.35; p < 0.001). In addition, RL-symptoms contribute to EDS in epilepsy patients as reflected by a higher mean ESS (5.2 vs. 8.1; unpaired t-test p = 0.01) and a higher percentage of patients with an ESS 10 (13% vs. 39%; p = 0.01).
Narcolepsy
An abnormal UNS score (cut-off 14 points) was seen in 3% of patients and 4% of controls. These high UNS scores were due in all but one subject to the subset of questions addressing EDS. In none of the patients/controls the diagnosis of narcolepsy was confirmed after clinical assessment.
Parasomnias
Overall, 60% in the epilepsy patients and 58% of the controls reported parasomnias. Sleep-wake transition parasomnias (night leg cramps, sleep starts, sleeptalking) were most commonly reported. The frequency of bruxism (19% vs. 10%, p = 0.07) and nightmares (16% vs. 6%, p = 0.04) was higher in controls than in epilepsy patients.
Symptoms suggestive of NREM-parasomnias (including sleep walking, sleep terror) and REM-sleep behavior disorder (violent acts in sleep or shouting during sleep) were rare in both groups (see Table 2 ).
Discussion
The present study confirms a higher frequency of subjective sleep disturbances, 2, 17, 19 but, with few exceptions (sleep maintenance insomnia, nightmares, and bruxism), similar sleep-wake habits and frequency of sleep disorders in a non-selected population of epilepsy patients as compared to controls. Although our control group recruited form hospital staff may be at least somehow biased by higher sleep complaints, the sleep-wake habits and prevalence of sleep disorders were similar to those reported in a study performed in an employed Swiss population of 1473 clerks of the Bern main post office. 29 In addition the estimated frequencies of EDS (14%), SA (3%), RL-symptoms (12%) and insomnia (28-38%) are similar to those reported in the literature.
Conversely, our results in the epilepsy patients contrast with previous studies, in which higher frequencies of EDS and/or sleep disorders were found. 3, 4, 9, 15, 20, 21, 23 Several factors may explain this discrepancy. First, the inclusion of selected patients (i.e. with distinct epilepsy syndromes 2, 3, 20 or medically refractory patients 9 ) or patients already referred to a sleep center for diagnostic work of sleep disorders 15, 20 may have led to an overestimation of EDS and sleep disorders in previous works. Second, we used validated scales for the assessment of EDS and SA. 3, 4 Third, the sample size was much higher in the present analysis as compared to some of previous studies. 3, 4, 20 Excessive daytime sleepiness Our study confirms that the frequency EDS is not increased in epilepsy patients as compared to controls. 2, 10, 19 Data on predictors of EDS in patients with epilepsy are contradictory. We found that EDS in epilepsy patients was predicted by a history of loud snoring, and by RL-symptoms but not by SA or epilepsy-related variables such as frequency of seizures and antiepileptic treatment. Malow et al. found that SA and RL-symptoms have a stronger impact on EDS than epilepsy related factors. 10 In contrast, SA and seizure frequency but not RL-symptoms were predictors EDS in the study of Manni et al. 19 In a recent Dutch the epilepsy group showed higher scores in most subscales of sleep disorders (including SA, PLMS, narcolepsy, snoring). 2 These differences may be explained also by the selection of the control group. Malow et al. compared epilepsy patients to other neurological patients. 10 The latter group is known to have higher frequency of sleep disorders. 30, 31 The control group in Manni's study is not described in detail. 19 A small subgroup of our epilepsy patients had severe EDS comparable to that of patients with narcolepsy (ESS > 14). 27 Most of them reported symptoms of RL-symptoms and were overweight older males presenting with loud habitual snoring (but no witnessed pauses in breathing) suggestive for SAS. Again, none of the epilepsy or AED related factors were associated with EDS.
Despite these results, epilepsy-and AED-related factors should not be neglected as potential contributors of EDS in single epilepsy patients. The effect of AEDs and seizures (daytime and nocturnal) and type of epilepsy on sleep architecture has been already demonstrated. 1, 6, 7, 32, 33 Sleep disorders, AEDs and seizure frequencies may influence each other. AEDs can worsen SAS and vice versa sleep disorder potential increase neuronal excitability due to its detrimental effect on sleep architecture in relation to sleep disorders and EDS. Adequate treatment of primary sleep disorders at least in sleep apnea syndrome in single patients did not only improve sleep quality and excessive daytime sleepiness but also potentially reduced seizure frequency. 12, 13, 16, 34 Restless legs symptoms (RL-symptoms)
Although frequency of RL-complaints was similar in epilepsy patients and controls, the contribution of restless legs symptoms to EDS in epilepsy patients is clinically relevant, as Restless Legs Syndrome (RLS) is a treatable sleep disorder. A similar high frequency of estimated RL-symptoms based on one question was found by Malow et al. 10 Reports on a higher comorbidity of Restless Legs Syndrome in epilepsy patients are confined to case reports to the occurrence of RLS under specific AED regimes. 35, 36 Therefore, clinicians should confirm diagnosis of RLS by using detailed interview or standardized questionaires and consider both dopaminergic medication and/or a change of AED as therapeutical options.
Sleep apnea (SA)
The similar frequency of SA in epilepsy patients and controls in this study is consistent with a study of a series of unselected epilepsy sample, 16 but contrasts recent results of higher frequencies of OSA in selected 9 and unselected epilepsy patients. 8 Our epilepsy patients with suspected SA had similar risk factors for SA as our controls with the exception of a higher BMI. None of the epilepsyor AED-related factors contributed independently to SA. This is consistent with the notion that in epilepsy patients established risk factors are associated with SA.
Parasomnias
For most parasomnias no differences in frequency were found between epilepsy patients and controls. This is in contrast with the frequent association between parasomnias and epilepsy in childhood. 37 In fact, several authors reported a high frequency of arousal disorders (sleep terror, sleepwalking) and headbanging in epileptic children. 38 The higher frequency of sleep complaints in our epilepsy sample may be related to psychiatric disorders. Comorbidity with anxiety and depression is higher in patients with epilepsy than in the general population 39 and would also explain the high frequency of sleep maintenance insomnia in our study. Unfortunately, we did not assess mood disorders and anxiety disorders in our sample. Another limitation of our study relates to the absence objective sleep tests (i.e. polysomnography, MSLT) to confirm suspected sleep disorders and the presence/severity of EDS.
